No news is bad newsThey should have clues if this thing is working or not by now and nothing in their behaviour points to that. No insider buying either. No news on anything. The table is being set for just that.. nothing. Anyone here think they can make their guidance numbers. I guess it's a lot to ask about a P1 onco trial that has not been all that good until now, that 3 years now.